About KemNet

KemNet provides pharmacists with revised formulations of popular pharmaceuticals tailored to specific patient demographics. This approach enhances therapeutic outcomes by addressing the unique needs of these groups, ensuring more effective medication management.

<problem> Many pharmaceutical formulations are designed for the average patient, potentially overlooking the unique physiological and metabolic differences within specific demographic groups. This one-size-fits-all approach can lead to suboptimal therapeutic outcomes and increased adverse effects in certain populations. </problem> <solution> KemNet offers reformulated versions of widely prescribed medications, customized to address the distinct needs of particular patient demographics. By considering factors such as age, sex, ethnicity, and genetic predispositions, KemNet aims to optimize drug efficacy and minimize potential side effects. This targeted approach allows healthcare providers to prescribe medications that are better suited to individual patient profiles, leading to improved treatment outcomes and enhanced patient safety. </solution> <features> - Reformulation of existing pharmaceuticals based on demographic-specific pharmacokinetic and pharmacodynamic data. - Clinical trials to validate the safety and efficacy of reformulated medications in target populations. - Partnerships with pharmaceutical manufacturers to produce and distribute customized drug formulations. - Development of proprietary algorithms to identify patient subgroups that would benefit most from reformulated medications. </features> <target_audience> KemNet's primary customers are pharmacists, physicians, and healthcare providers seeking to improve medication management and patient outcomes through personalized pharmaceutical solutions. </target_audience>

What does KemNet do?

Where is KemNet located?

KemNet is based in Edmonton, Canada.

When was KemNet founded?

KemNet was founded in 2022.

Who founded KemNet?

KemNet was founded by Morẹ́nikẹ́ Ẹniọlá Ọláòṣebìkan.

Morẹ́nikẹ́ Ẹniọlá Ọláòṣebìkan - CEO/Founder

Location

Edmonton, Canada

Founded

2022

Employees

1 employees

Looking for specific startups?

Try our free semantic startup search

KemNet

Score: 41/100

AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

kemnet.ca 1K+

Founded 2022 – Edmonton, Canada

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

Morẹ́nikẹ́ Ẹniọlá Ọláòṣebìkan

CEO/Founder

Company Description

Problem

Many pharmaceutical formulations are designed for the average patient, potentially overlooking the unique physiological and metabolic differences within specific demographic groups. This one-size-fits-all approach can lead to suboptimal therapeutic outcomes and increased adverse effects in certain populations.

Solution

KemNet offers reformulated versions of widely prescribed medications, customized to address the distinct needs of particular patient demographics. By considering factors such as age, sex, ethnicity, and genetic predispositions, KemNet aims to optimize drug efficacy and minimize potential side effects. This targeted approach allows healthcare providers to prescribe medications that are better suited to individual patient profiles, leading to improved treatment outcomes and enhanced patient safety.

Features

Reformulation of existing pharmaceuticals based on demographic-specific pharmacokinetic and pharmacodynamic data.

Clinical trials to validate the safety and efficacy of reformulated medications in target populations.

Partnerships with pharmaceutical manufacturers to produce and distribute customized drug formulations.

Development of proprietary algorithms to identify patient subgroups that would benefit most from reformulated medications.

Target Audience

KemNet's primary customers are pharmacists, physicians, and healthcare providers seeking to improve medication management and patient outcomes through personalized pharmaceutical solutions.